title: Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Greenberger
authors.forename: Mark
authors.initials: M
authors.lastname: Ballow
authors.forename: Thomas B
authors.initials: TB
authors.lastname: Casale
authors.forename: Thomas A E
authors.initials: TA
authors.lastname: Platts-Mills
authors.forename: Hugh A
authors.initials: HA
authors.lastname: Sampson
mesh_terms: D000286:Administration, Sublingual; D000485:Allergens / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000574:American Medical Association; D003888:Desensitization, Immunologic / Q000379:methods* / Q000639:trends; D006801:Humans; D007279:Injections, Subcutaneous; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
chemical_list: D000485:Allergens